0001209191-17-045911.txt : 20170721
0001209191-17-045911.hdr.sgml : 20170721
20170721160105
ACCESSION NUMBER: 0001209191-17-045911
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170720
FILED AS OF DATE: 20170721
DATE AS OF CHANGE: 20170721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stein Steven H
CENTRAL INDEX KEY: 0001673776
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 17976611
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-20
0
0000879169
INCYTE CORP
INCY
0001673776
Stein Steven H
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP & Chief Medical Officer
Common Stock
2017-07-20
4
M
0
1191
88.68
A
19356
D
Common Stock
2017-07-20
4
M
0
4772
83.83
A
24128
D
Common Stock
2017-07-20
4
M
0
522
95.76
A
24650
D
Common Stock
2017-07-20
4
S
0
1191
131.09
D
23459
D
Common Stock
2017-07-20
4
S
0
4772
131.09
D
18687
D
Common Stock
2017-07-20
4
S
0
522
131.09
D
18165
D
Non-Qualified Stock Option (right to buy)
88.68
2017-07-20
4
M
0
1191
0.00
D
2022-03-01
Common Stock
1191
8687
D
Non-Qualified Stock Option (right to buy)
83.83
2017-07-20
4
M
0
4772
0.00
D
2026-07-14
Common Stock
4772
13723
D
Non-Qualified Stock Option (right to buy)
95.76
2017-07-20
4
M
0
522
0.00
D
2023-01-06
Common Stock
522
8870
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Represents weighted average sale price. Actual sale prices ranged from $129.57 - $132.10.
Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
This includes an 18,165 aggregate of shares of common stock issuable pursuant to previously reported restricted stock units that have not vested
Beginning March 2, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning July 15, 2016, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Beginning January 7, 2016, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years
/s/ Steven Stein
2017-07-21